Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Matica Enterprises Inc. (C:MMJ)

Business Focus: Alternative Medicine

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for MMJ within the last 6 months
See all filings within the past 6 months

Company News

Feb 24, 2020 08:30 ET
Matica Subsidiary Receives Sales Licence
TORONTO, ONTARIO / ACCESSWIRE / February 24, 2020 / Matica Enterprises Inc. (CSE:MMJ) (Frankfurt: 39N) (OTCQB:MMJFF) ("Matica" or the "Company") is pleased to announce that its subsidiary, RoyalMax Biotechnology Canada Inc. ("RoyalMax"), has received both the Standard Processing and Sale For Medical Purposes Licences from Health Canada. The standard processing licence will allow RoyalMax to deliver products to the recreational market throughout Canada. With the medical sales licence RoyalMax, will be able to provide product directly to appro
Read full article
Feb 11, 2020 16:55 ET
Matica's Interest in RoyalMax Released
TORONTO, ON / ACCESSWIRE / February 11, 2020 / Matica Enterprises Inc. CSE:MMJ) (Frankfurt:39N) (OTCQB:MMJFF) ("Matica" or the "Company") is pleased to announce that Matica has closed the RoyalMax Biotechnology Canada Inc. ("RoyalMax") acquisition and formally taken its 70 per cent earned interest in RoyalMax. On April 6th, 2017 the Company signed a definitive agreement ("the agreement") allowing for Matica to become a majority owner (70%) of RoyalMax, at the time a late stage applicant under the then Access to Cannabis f
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Mar 31, 2020202,282-3,472
Mar 15, 2020205,754109,293
Feb 29, 202096,46121,700
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Matica Enterprises Inc is a Canada-based company engaged in alternative medicine sector. The Company invests in cannabis growing facility in Dorval Quebec, Hemmingford project and Yunify Natural Technologies. Cannabis growing facility in Dorval Quebec is fully climate controlled with automated plant nutrient systems. Hemmingford project is rural community south of Montreal, where the Company establishes sections of greenhouses for growing cannabis. In addition to a greenhouse project, this property allows for growing cannabis outdoors as well. Yunify Natural Technologies is a Quebec-based health and personal care research and innovation technology company. It creates personal care products and agricultural products. It focuses on three core business pillars: consumer personal care and nutraceuticals, agriculture and greenhouse growth inputs and functional innovations in related industries through discovery licensing.

See business summary



Search (past week) for $MMJ.CA

  • No tweets found